EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.4100
-0.0050 (-1.20%)
Sep 18, 2026, 11:52 AM AEST
EZZ Life Science Holdings Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 20 | 17 | 110 | 82 | 21 | 13 | |
Market Cap Growth | -81.76% | -84.44% | 34.71% | 283.76% | 61.08% | -29.08% |
Enterprise Value | 10 | 3 | 91 | 70 | 12 | 4 |
Last Close Price | 0.41 | 0.36 | 2.32 | 1.80 | 0.47 | 0.28 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | 16.40 | 11.77 | 5.88 | 10.10 |
Forward PE | - | 9.36 | 12.38 | 7.87 | 8.13 | - |
PS Ratio | 0.42 | 0.37 | 1.65 | 1.23 | 0.57 | 0.88 |
PB Ratio | 0.80 | 0.70 | 3.93 | 3.84 | 1.46 | 1.16 |
P/TBV Ratio | 0.80 | 0.70 | 3.93 | 3.85 | 1.47 | 1.17 |
P/FCF Ratio | - | - | 26.76 | 14.29 | 5.46 | 6.99 |
P/OCF Ratio | - | - | 25.26 | 13.34 | 5.32 | 6.97 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.22 | 0.06 | 1.36 | 1.05 | 0.32 | 0.29 |
EV/EBITDA Ratio | - | - | 9.02 | 7.14 | 2.55 | 2.41 |
EV/EBIT Ratio | - | - | 9.16 | 7.17 | 2.56 | 2.43 |
EV/FCF Ratio | - | - | 22.05 | 12.14 | 3.02 | 2.29 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.03 | 0.01 | 0.10 | 0.05 |
Debt / FCF Ratio | - | - | 0.07 | 0.02 | 0.12 | 0.06 |
Net Debt / Equity Ratio | -0.38 | -0.38 | -0.76 | -0.91 | -0.96 | -0.91 |
Net Debt / EBITDA Ratio | 1.51 | 1.51 | -2.13 | -1.99 | -3.04 | -5.76 |
Net Debt / FCF Ratio | 1.05 | 1.05 | -5.20 | -3.39 | -3.60 | -5.46 |
Asset Turnover | 1.50 | 1.50 | 2.25 | 3.08 | 2.33 | 1.14 |
Inventory Turnover | 4.65 | 4.65 | 8.95 | 13.79 | 14.86 | 25.73 |
Quick Ratio | 5.41 | 5.41 | 4.59 | 5.33 | 5.43 | 4.53 |
Current Ratio | 8.70 | 8.70 | 5.77 | 5.96 | 5.80 | 4.96 |
Return on Equity (ROE) | -20.25% | -20.25% | 27.24% | 38.79% | 27.95% | 12.21% |
Return on Assets (ROA) | -13.41% | -13.41% | 20.86% | 28.12% | 18.08% | 8.48% |
Return on Invested Capital (ROIC) | -43.33% | -60.35% | 148.27% | 573.17% | 446.69% | 111.46% |
Return on Capital Employed (ROCE) | -26.80% | -26.80% | 35.20% | 45.50% | 31.40% | 15.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -27.25% | -30.99% | 6.10% | 8.50% | 17.00% | 9.90% |
FCF Yield | -45.02% | -51.19% | 3.74% | 7.00% | 18.32% | 14.30% |
Dividend Yield | 9.76% | - | 1.72% | 1.95% | 4.20% | 1.59% |
Payout Ratio | - | - | 27.00% | 15.53% | 16.54% | 13.20% |
Buyback Yield / Dilution | -1.76% | -1.77% | -7.35% | -0.89% | -0.46% | -25.23% |
Total Shareholder Return | 6.24% | -1.77% | -5.62% | 1.06% | 3.74% | -23.64% |